1 IN. DI LETTURA
Jan 23 (Reuters) - Barr Pharmaceuticals Inc BRL.N said the U.S. Patent and Trademark Office issued a patent for its Seasonique extended-cycle oral contraceptive.
The patent will expire on Jan. 30, 2024, the company said in a statement. (Reporting by Neetha Mahadevan in Bangalore; Editing by Deepak Kannan)